CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Morinidazole

吗啉硝唑 杂质对照品Morinidazole Impurities

33 个杂质条目33 impurity entries

本页汇总 吗啉硝唑 的 33 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 33 impurity reference standards of Morinidazole. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吗啉硝唑(Morinidazole)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of an HPLC-QAMS method for simultaneous quantification of two morinidazole impurities, three ornidazole impurities and one levornidazole impurity in morinidazole sodium chloride injection
    Pakistan journal of pharmaceutical sciences · 2026 · Lin J et al.  ·  PMID 41879414  ·  DOI
  2. 分析方法Analytical MethodsSimultaneous determination of morinidazole, its N-oxide, sulfate, and diastereoisomeric N(+)-glucuronides in human plasma by liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · Gao R et al.  ·  PMID 23122401  ·  DOI
  3. 分析方法Analytical MethodsA chiral high-performance liquid chromatography-tandem mass spectrometry method for the stereospecific determination of morinidazole in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2014 · Zhong K et al.  ·  PMID 24858695  ·  DOI
  4. 分析方法Analytical MethodsComment on "Simultaneous quantification of metronidazole, tinidazole, ornidazole and morinidazole in human saliva": Saliva or gingival crevicular fluid?
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013 · Jiang Y et al.  ·  PMID 23314355  ·  DOI
  5. 分析方法Analytical MethodsSimultaneous quantification of metronidazole, tinidazole, ornidazole and morinidazole in human saliva
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2012 · Wang Y et al.  ·  PMID 22658465  ·  DOI

吗啉硝唑 —— 原料药与杂质对照品Morinidazole — drug substance & impurities

共 34 个条目(含原料药本体)34 items incl. the drug substance
Morinidazole structure
原料药 APIAPI
吗啉硝唑Morinidazole
Morinidazole
CAS No.92478-27-8
Chemical FormulaC11H18N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 1 structure
1
吗啉硝唑杂质1Morinidazole Impurity 1
Morinidazole Impurity 1
CAS No.1807608-29-2
Chemical FormulaC11H18N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 2 structure
2
吗啉硝唑杂质2Morinidazole Impurity 2
Morinidazole Impurity 2
CAS No.1415561-33-9
Chemical FormulaC9H16N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 3 structure
3
吗啉硝唑杂质3Morinidazole Impurity 3
Morinidazole Impurity 3
CAS No.1413431-48-7
Chemical FormulaC11H18N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 4 structure
4
吗啉硝唑杂质4Morinidazole Impurity 4
Morinidazole Impurity 4
CAS No.1782143-94-5
Chemical FormulaC11H18N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 5 structure
5
吗啉硝唑杂质5Morinidazole Impurity 5
Morinidazole Impurity 5
CAS No.1807608-40-7
Chemical FormulaC11H19N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 8 structure
8
吗啉硝唑杂质8Morinidazole Impurity 8
Morinidazole Impurity 8
CAS No.1413431-46-5
Chemical FormulaC11H18N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 9 (S-Morinidazole Glucuronide) structure
9
吗啉硝唑杂质9 (S-吗啉硝唑 葡糖苷酸)Morinidazole Impurity 9 (S-Morinidazole Glucuronide)
Morinidazole Impurity 9 (S-Morinidazole Glucuronide)
CAS No.1413431-50-1
Chemical FormulaC17H27N4O10+
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 10 (R-Morinidazole Glucuronide) structure
10
吗啉硝唑杂质10 (R-吗啉硝唑 葡糖苷酸)Morinidazole Impurity 10 (R-Morinidazole Glucuronide)
Morinidazole Impurity 10 (R-Morinidazole Glucuronide)
CAS No.1413431-52-3
Chemical FormulaC17H27N4O10+
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 11 (R-Morinidazole) structure
11
吗啉硝唑杂质11(R-吗啉硝唑)Morinidazole Impurity 11 (R-Morinidazole)
Morinidazole Impurity 11 (R-Morinidazole)
CAS No.898230-59-6
Chemical FormulaC11H18N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 13 structure
13
吗啉硝唑杂质13Morinidazole Impurity 13
Morinidazole Impurity 13
CAS No.1314991-57-5
Chemical FormulaC4H6N4O
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 14 structure
14
吗啉硝唑杂质14Morinidazole Impurity 14
Morinidazole Impurity 14
CAS No.1696-20-4
Chemical FormulaC6H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 16 structure
16
吗啉硝唑杂质16Morinidazole Impurity 16
Morinidazole Impurity 16
CAS No.87008-47-7
Chemical FormulaC11H18N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 18 structure
18
吗啉硝唑杂质18Morinidazole Impurity 18
Morinidazole Impurity 18
CAS No.2213449-45-5
Chemical FormulaC11H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 24 structure
24
吗啉硝唑杂质24Morinidazole Impurity 24
Morinidazole Impurity 24
CAS No.126664-27-5
Chemical FormulaC9H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 25 structure
25
吗啉硝唑杂质25Morinidazole Impurity 25
Morinidazole Impurity 25
CAS No.1242818-13-8
Chemical FormulaC11H16N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 26 structure
26
吗啉硝唑杂质26Morinidazole Impurity 26
Morinidazole Impurity 26
CAS No.2750387-66-5
Chemical FormulaC20H35N7O6
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 31 structure
31
吗啉硝唑杂质31Morinidazole Impurity 31
Morinidazole Impurity 31
CAS No.95881-05-3
Chemical FormulaC11H14N6O5
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 37 structure
37
吗啉硝唑杂质37Morinidazole Impurity 37
Morinidazole Impurity 37
CAS No.87008-38-6
Chemical FormulaC12H21N4O4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 40 structure
40
吗啉硝唑杂质40Morinidazole Impurity 40
Morinidazole Impurity 40
CAS No.157493-58-8
Chemical FormulaC18H28N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 41 structure
41
吗啉硝唑杂质41Morinidazole Impurity 41
Morinidazole Impurity 41
CAS No.76142-10-4
Chemical FormulaC9H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 44 structure
44
吗啉硝唑杂质44Morinidazole Impurity 44
Morinidazole Impurity 44
CAS No.40893-69-4
Chemical FormulaC7H14ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 45 structure
45
吗啉硝唑杂质45Morinidazole Impurity 45
Morinidazole Impurity 45
CAS No.2119729-42-7
Chemical FormulaC8H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 46 structure
46
吗啉硝唑杂质46Morinidazole Impurity 46
Morinidazole Impurity 46
CAS No.2119729-43-8
Chemical FormulaC9H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 47 structure
47
吗啉硝唑杂质47Morinidazole Impurity 47
Morinidazole Impurity 47
CAS No.123-90-0
Chemical FormulaC4H9NS
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 48 (N-Nitroso Morinidazole Impurity 47) structure
48
吗啉硝唑杂质48 (N-亚硝基吗啉硝唑杂质47)Morinidazole Impurity 48 (N-Nitroso Morinidazole Impurity 47)
Morinidazole Impurity 48 (N-Nitroso Morinidazole Impurity 47)
CAS No.26541-51-5
Chemical FormulaC4H8N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 53 structure
53
吗啉硝唑杂质53Morinidazole Impurity 53
Morinidazole Impurity 53
CAS No.39849-45-1
Chemical FormulaC7H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 54 structure
54
吗啉硝唑杂质54Morinidazole Impurity 54
Morinidazole Impurity 54
CAS No.6425-32-7
Chemical FormulaC7H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 56 structure
56
吗啉硝唑杂质56Morinidazole Impurity 56
Morinidazole Impurity 56
CAS No.24880-24-8
Chemical FormulaC12H10N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 59 (N-Nitroso Morinidazole Impurity 58) structure
59
吗啉硝唑杂质59 (N-亚硝基吗啉硝唑杂质58)Morinidazole Impurity 59 (N-Nitroso Morinidazole Impurity 58)
Morinidazole Impurity 59 (N-Nitroso Morinidazole Impurity 58)
CAS No.2245709-19-5
Chemical FormulaC4H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 62 structure
62
吗啉硝唑杂质62Morinidazole Impurity 62
Morinidazole Impurity 62
CAS No.83341-99-5
Chemical FormulaC7H14ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 63 structure
63
吗啉硝唑杂质63Morinidazole Impurity 63
Morinidazole Impurity 63
CAS No.4580-83-0
Chemical FormulaC7H13Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 63 Hydrochloride structure
63
吗啉硝唑杂质63 盐酸盐Morinidazole Impurity 63 Hydrochloride
Morinidazole Impurity 63 Hydrochloride
CAS No.50786-85-1
Chemical FormulaC7H13Cl2NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Morinidazole Impurity 64 structure
64
吗啉硝唑杂质64Morinidazole Impurity 64
Morinidazole Impurity 64
CAS No.2937-98-6
Chemical FormulaC9H19NO
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吗啉硝唑 —— 研究文献与合成路线Morinidazole — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吗啉硝唑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Morinidazole. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development of an HPLC-QAMS method for simultaneous quantification of two morinidazole impurities, three ornidazole impurities and one levornidazole impurity in morinidazole sodium chloride injection
    Lin J, Xu P, Zhang H, et al. · Pakistan journal of pharmaceutical sciences · 2026

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吗啉硝唑 杂质谱研究要点Morinidazole — impurity profiling notes

下面这些是拿到 吗啉硝唑 的 34 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 34 impurity entries for Morinidazole, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances